{"nct_id":"NCT05870579","title":"[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2023-11-13","start_date_type":"ACTUAL","primary_completion_date":"2026-12-30","primary_completion_date_type":"ESTIMATED","completion_date":"2032-01-26","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["NVS"]}